HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors

Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the...

Full description

Bibliographic Details
Main Authors: Evan Tan, Cara Sze Hui Chin, Zhi Feng Sherman Lim, Say Kong Ng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.796991/full
_version_ 1818987153995071488
author Evan Tan
Cara Sze Hui Chin
Zhi Feng Sherman Lim
Say Kong Ng
author_facet Evan Tan
Cara Sze Hui Chin
Zhi Feng Sherman Lim
Say Kong Ng
author_sort Evan Tan
collection DOAJ
description Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more “human-like” post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.
first_indexed 2024-12-20T19:02:10Z
format Article
id doaj.art-3039674df5144cb3b24da5f9ef91cc9f
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-20T19:02:10Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-3039674df5144cb3b24da5f9ef91cc9f2022-12-21T19:29:21ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-12-01910.3389/fbioe.2021.796991796991HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral VectorsEvan TanCara Sze Hui ChinZhi Feng Sherman LimSay Kong NgAnimal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more “human-like” post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.https://www.frontiersin.org/articles/10.3389/fbioe.2021.796991/fullHEK293human embryonic kidney cell 293biotechnologyviral vectorsviral vectored vaccinesbiotherapeutics and biologics
spellingShingle Evan Tan
Cara Sze Hui Chin
Zhi Feng Sherman Lim
Say Kong Ng
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Frontiers in Bioengineering and Biotechnology
HEK293
human embryonic kidney cell 293
biotechnology
viral vectors
viral vectored vaccines
biotherapeutics and biologics
title HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
title_full HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
title_fullStr HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
title_full_unstemmed HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
title_short HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
title_sort hek293 cell line as a platform to produce recombinant proteins and viral vectors
topic HEK293
human embryonic kidney cell 293
biotechnology
viral vectors
viral vectored vaccines
biotherapeutics and biologics
url https://www.frontiersin.org/articles/10.3389/fbioe.2021.796991/full
work_keys_str_mv AT evantan hek293celllineasaplatformtoproducerecombinantproteinsandviralvectors
AT caraszehuichin hek293celllineasaplatformtoproducerecombinantproteinsandviralvectors
AT zhifengshermanlim hek293celllineasaplatformtoproducerecombinantproteinsandviralvectors
AT saykongng hek293celllineasaplatformtoproducerecombinantproteinsandviralvectors